Thrombocytopenias due to gray platelet syndrome or THC2 mutations

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 6, 2011, Pages 690-697

  Di Paola, Jorge ^a   Johnson, Jan ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

Author keywords

ACBD5; ANKRD26; gray platelet syndrome; MASTL kinase; megakaryocyte development; THC2; Thrombocytopenia

Indexed keywords

ACYL COENZYME A BINDING DOMAIN CONTAINING PROTEIN 5; ANKYRIN; ANKYRIN REPEAT DOMAIN 26 PROTEIN; BINDING PROTEIN; MICROTUBULE ASSOCIATED SERINE THREONINE LIKE KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 10P; CHROMOSOME 3P; GENE LOCUS; GENE MUTATION; GRAY PLATELET SYNDROME; HUMAN; MEGAKARYOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 3; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GRAY PLATELET SYNDROME; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; THROMBOCYTOPENIA;

EID: 81755186816     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1291379     Document Type: Article

References (52)

1. OMIM. (Online Mendelian Inheritance in Man. http://www.ncbi.nlm.nih.gov/ omim Accessed: 9 September 2011
2. Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med 1971 51 6 818-828
3. Gerrard J M., Phillips D R., Rao G H. et al. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest 1980 66 1 102-109
4. White J G. Ultrastructural studies of the gray platelet syndrome. Am J Pathol 1979 95 2 445-462
5. Nurden A T., Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007 21 1 21-36
6. Hayward C P., Weiss H J., Lages B et al. The storage defects in grey platelet syndrome and alphadelta-storage pool deficiency affect alpha-granule factor V and multimerin storage without altering their proteolytic processing. Br J Haematol 2001 113 4 871-877
7. Breton-Gorius J, Vainchenker W, Nurden A, Levy-Toledano S, Caen J. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol 1981 102 1 10-19
8. Drouin A, Favier R, Massé J M. et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001 98 5 1382-1391
9. Mitjavila M T., Vinci G, Villeval J L. et al. Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta). J Cell Physiol 1988 134 1 93-100
10. Rosa J P., George J N., Bainton D F., Nurden A T., Caen J P., McEver R P. Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest 1987 80 4 1138-1146
11. Gebrane-Younès J, Cramer E M., Orcel L, Caen J P. Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells. J Clin Invest 1993 92 6 3023-3028
12. Falik-Zaccai T C., Anikster Y, Rivera C E. et al. A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics. Mol Genet Metab 2001 74 3 303-313
13. Gunay-Aygun M, Zivony-Elboum Y, Gumruk F et al. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood 2010 116 23 4990-5001
14. Lo B, Li L, Gissen P et al. Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood 2005 106 13 4159-4166
15. White J G., Key N S., King R A., Vercellotti G M. The White platelet syndrome: a new autosomal dominant platelet disorder. Platelets 2004 15 3 173-184
16. White J G. Medich giant platelet disorder: a unique alpha granule deficiency I. Structural abnormalities. Platelets 2004 15 6 345-353
17. Kimura Y, Hart A, Hirashima M et al. Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis. J Exp Med 2002 195 7 941-952
18. Detter J C., Zhang Q, Mules E H. et al. Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis. Proc Natl Acad Sci U S A 2000 97 8 4144-4149
19. Tiwari S, Italiano J E. Jr, Barral D C. et al. A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood 2003 102 12 3970-3979
20. Balduini C L., De Candia E, Savoia A. Why the disorder induced by GATA1 Arg216Gln mutation should be called X-linked thrombocytopenia with thalassemia rather than X-linked gray platelet syndrome Blood 2007 110 7 2770-2771 author reply 2771
21. Mori K, Suzuki S, Akutsu Y, Ishikawa M, Sakai H. Gray platelet syndrome: relationship between morphological abnormality of the dense tubular system (DTS) and intracellular Ca++mobilization in the platelet. Nippon Ketsueki Gakkai Zasshi 1989 52 8 1534-1541
22. Tubman V N., Levine J E., Campagna D R. et al. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood 2007 109 8 3297-3299
23. Oh J, Ho L, Ala-Mello S et al. Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet 1998 62 3 593-598
24. Bénit L, Cramer E M., Massé J M., Dusanter-Fourt I, Favier R. Molecular study of the hematopoietic zinc finger gene in three unrelated families with gray platelet syndrome. J Thromb Haemost 2005 3 9 2077-2080
25. Chiang A P., Beck J S., Yen H J. et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc Natl Acad Sci U S A 2006 103 16 6287-6292
26. Walsh T, Shahin H, Elkan-Miller T et al. Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet 2010 87 1 90-94
27. Fabbro S, Kahr W H., Hinckley J et al. Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for gray platelet syndrome and narrows the interval significantly. Blood 2011 117 12 3430-3434
28. Lander E S., Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science 1987 236 4808 1567-1570
29. Alkan C, Sajjadian S, Eichler E E. Limitations of next-generation genome sequence assembly. Nat Methods 2011 8 1 61-65
30. Iolascon A, Perrotta S, Amendola G et al. Familial dominant thrombocytopenia: clinical, biologic, and molecular studies. Pediatr Res 1999 46 5 548-552
31. Bithell T C., Didisheim P, Cartwright G E., Wintrobe M M. Thrombocytopenia inherited as an autosomal dominant trait. Blood 1965 25 231-240
32. Savoia A, Del Vecchio M, Totaro A et al. An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p. Am J Hum Genet 1999 65 5 1401-1405
33. Drachman J G., Jarvik G P., Mehaffey M G. Autosomal dominant thrombocytopenia: incomplete megakaryocyte differentiation and linkage to human chromosome 10. Blood 2000 96 1 118-125
34. Gandhi M J., Cummings C L., Drachman J G. FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10. Hum Hered 2003 55 1 66-70
35. Johnson H J., Gandhi M J., Shafizadeh E et al. In vivo inactivation of MASTL kinase results in thrombocytopenia. Exp Hematol 2009 37 8 901-908
36. Woo A J., Moran T B., Schindler Y L. et al. Identification of ZBP-89 as a novel GATA-1-associated transcription factor involved in megakaryocytic and erythroid development. Mol Cell Biol 2008 28 8 2675-2689
37. Amigo J D., Ackermann G E., Cope J J. et al. The role and regulation of friend of GATA-1 (FOG-1) during blood development in the zebrafish. Blood 2009 114 21 4654-4663
38. VonDerLinden D, Ma X, Sandberg E M., Gernert K, Bernstein K E., Sayeski P P. Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity. Mol Cell Biochem 2002 241 1-2 87-94
39. Yu J, Fleming S L., Williams B et al. Greatwall kinase: a nuclear protein required for proper chromosome condensation and mitotic progression in Drosophila. J Cell Biol 2004 164 4 487-492
40. Yu J, Zhao Y, Li Z, Galas S, Goldberg M L. Greatwall kinase participates in the Cdc2 autoregulatory loop in Xenopus egg extracts. Mol Cell 2006 22 1 83-91
41. Burgess A, Vigneron S, Brioudes E, Labbé J C., Lorca T, Castro A. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A 2010 107 28 12564-12569
42. Lorca T, Bernis C, Vigneron S et al. Constant regulation of both the MPF amplification loop and the Greatwall-PP2A pathway is required for metaphase II arrest and correct entry into the first embryonic cell cycle. J Cell Sci 2010 123 Pt 13 2281-2291
43. Gharbi-Ayachi A, Labbé J C., Burgess A et al. The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science 2010 330 6011 1673-1677
44. Mochida S, Maslen S L., Skehel M, Hunt T. Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science 2010 330 6011 1670-1673
45. Punzo F, Mientjes E J., Rohe C F. et al. A mutation in the acyl-coenzyme A binding domain-containing protein 5 gene (ACBD5) identified in autosomal dominant thrombocytopenia. J Thromb Haemost 2010 8 9 2085-2087
46. Pippucci T, Savoia A, Perrotta S et al. Mutations in the 5 UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet 2011 88 1 115-120
47. Soupene E, Fyrst H, Kuypers F A. Mammalian acyl-CoA: lysophosphatidylcholine acyltransferase enzymes. Proc Natl Acad Sci U S A 2008 105 1 88-93
48. Fan J, Liu J, Culty M, Papadopoulos V. Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog Lipid Res 2010 49 3 218-234
49. Bera T K., Liu X F., Yamada M et al. A model for obesity and gigantism due to disruption of the Ankrd26 gene. Proc Natl Acad Sci U S A 2008 105 1 270-275
50. Kahr W HA, Hinckley J, Li L et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 2011 43 8 738-740
51. Gunay-Aygun M, Falik-Zaccai T C., Vilboux T et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet a-granules. Nat Genet 2011 43 8 732-734
52. Albers C.A., Cvejic A., Favier R., et al., Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet. 2011 43 8 735-737.